Clinical Trials

3 studies in Cardiopulmonary bypass

1. CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass Scottsdale and Phoenix, AZ View Summary
   Close

   CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

   Location:

   Scottsdale and Phoenix, AZ

   Trial status:

   Open for Enrollment

   Why is this study being done?

   The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.

   NCT ID:

   NCT00819793

   • Print Summary
   • View study details

   Who can I contact for additional information about this study?

   
   Scottsdale: Andre Watkins
                       
   
   

2. Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery Rochester, MN View Summary
   Close

   Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   We conducted a single center prospective trial of infants (≤ 365 days of age) who presented to a single institution for congenital cardiac surgery. Blood was collected from study participants at 7 time points; 1) post-anesthesia induction, 2) post-CPB/pre-MUF, 3) Intensive care unit (ICU) arrival, 4) post-op hour 4, 5) post-op hour 8, 6) post-op hour 12, and 7) post-op hour 24. At each of the 7 time points blood was analyzed for levels of the following; dexamethasone, cortisol, ACTH, Interleukin (IL) 10, IL 8, and IL 6. In addition, the innate stress response was evaluated with a cosyntropin stimulation test. Each patient received a 1 mcg/1.73 m2 intravenous dose of cosyntropin at; anesthesia induction, prior to dexamethasone (time 1), ICU arrival (time 3), and 24 hours after ICU arrival (time 7). Cortisol levels were measured before (time 1, 3, and 7) and 30 minutes after cosyntropin administration (time 1a, 3a, and 7a).

   NCT ID:

   NCT01839812

   IRB Number:

   08-001638

   • Print Summary
   • View study details
3. Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery Rochester, MN View Summary
   Close

   Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

   Location:

   Rochester, MN

   Trial status:

   Open for Enrollment

   Why is this study being done?

   The objective of this study is to prospectively evaluate the response of recombinant antithrombin (rAT) (ATRYN) in patients who are heparin resistant and are scheduled to undergo cardiac surgery.

   NCT ID:

   NCT01547728

   IRB Number:

   11-004125

   • Print Summary
   • View study details